Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension

Journal of Hypertension, Supplement

Volumn 13, Issue 1, 1995, Pages

  Mallion, J M ^a   Bradstreet, D C ^a   Makris, L ^a   Goldberg, A I ^a   Halasz, S ^a   Sweet, C S ^a   Lim, N Y ^a   Madonna, O ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin II; Antihypertensive agents; Captopril; Hypertension; Losartan

Indexed keywords

ANGIOTENSIN RECEPTOR; CAPTOPRIL; LOSARTAN POTASSIUM; POTASSIUM; URIC ACID;

ADULT; ANTIHYPERTENSIVE ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION; URIC ACID BLOOD LEVEL; VERTIGO;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED;

EID: 0029165196     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)